ABIN951720
antibody from antibodies-online
Targeting: MIA2
cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN951720 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-CTAGE Family, Member 5 (CTAGE5) (AA 774-804), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 774-804, C-Term
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.
MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies.
Wu C, Ma MH, Brown KR, Geisler M, Li L, Tzeng E, Jia CY, Jurisica I, Li SS
Proteomics 2007 Jun;7(11):1775-85
Proteomics 2007 Jun;7(11):1775-85
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M
Cell 2006 Nov 3;127(3):635-48
Cell 2006 Nov 3;127(3):635-48
cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing.
Usener D, Schadendorf D, Koch J, Dübel S, Eichmüller S
The Journal of investigative dermatology 2003 Jul;121(1):198-206
The Journal of investigative dermatology 2003 Jul;121(1):198-206
MGEA6 is tumor-specific overexpressed and frequently recognized by patient-serum antibodies.
Comtesse N, Niedermayer I, Glass B, Heckel D, Maldener E, Nastainczyk W, Feiden W, Meese E
Oncogene 2002 Jan 10;21(2):239-47
Oncogene 2002 Jan 10;21(2):239-47
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC